APPLICATION
ANDA090641
TYPE
ANDA
ORIGINAL APPROVAL
2010-07-28
LATEST ACTION
2020-07-20
ROUTE
SUBCUTANEOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
SUMATRIPTAN SUCCINATEDiscontinued
SUMATRIPTAN SUCCINATE EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) · INJECTABLE · SUBCUTANEOUS
Approval history
2020-07-20Labeling · Supplement 8 · standardAP
2020-07-20Labeling · Supplement 6 · standardAP
2015-09-01Labeling · Supplement 1AP
2015-09-01Labeling · Supplement 4 · standardAP
2015-09-01Labeling · Supplement 3 · standardAP
2010-07-28OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.